SAB Biotherapeutics' Angel Round

SAB Biotherapeutics raised a round of funding on January 01, 2014. Investors include T. Denny Sanford.

SAB Biotherapeutics (SAB), headquartered in Sioux Falls, S.D. is a clinical stage, biopharmaceutical development company focused on the manufacturing of antibody therapeutics. SAB delivers a platform …

Articles about SAB Biotherapeutics' Angel Round: